Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06JFN
|
|||
| Former ID |
DNC009665
|
|||
| Drug Name |
N-benzyl-4-bromo-3-(morpholinosulfonyl)benzamide
|
|||
| Synonyms |
CHEMBL475493; Cambridge id 5211146; AC1LL0O9; Oprea1_380259; N-benzyl-4-bromo-3-(morpholinosulfonyl)benzamide; CBDivE_007294; SCHEMBL5623492; MolPort-002-316-866; BDBM50277135; AKOS008461950; MCULE-3410949273; AB00075261-01; SR-01000198591; SR-01000198591-1
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H19BrN2O4S
|
|||
| Canonical SMILES |
C1COCCN1S(=O)(=O)C2=C(C=CC(=C2)C(=O)NCC3=CC=CC=C3)Br
|
|||
| InChI |
1S/C18H19BrN2O4S/c19-16-7-6-15(18(22)20-13-14-4-2-1-3-5-14)12-17(16)26(23,24)21-8-10-25-11-9-21/h1-7,12H,8-11,13H2,(H,20,22)
|
|||
| InChIKey |
DEVYAXBKQQLYGQ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | CB2 selective sulfamoyl benzamides: optimization of the amide functionality. Bioorg Med Chem Lett. 2009 Jan 15;19(2):309-13. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.